Guangzhou Wondfo Biotech Co.,Ltd

SZSE:300482 Stock Report

Market Cap: CN¥12.6b

Guangzhou Wondfo BiotechLtd Past Earnings Performance

Past criteria checks 5/6

Guangzhou Wondfo BiotechLtd has been growing earnings at an average annual rate of 1.1%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 6.8% per year. Guangzhou Wondfo BiotechLtd's return on equity is 9.5%, and it has net margins of 17.8%.

Key information

1.1%

Earnings growth rate

0.8%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate6.8%
Return on equity9.5%
Net Margin17.8%
Last Earnings Update30 Sep 2024

Recent past performance updates

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 01
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

Apr 29
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

Recent updates

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 01
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Shareholders May Want To Dig Deeper Than Statutory Profit

Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Sep 06
Cautious Investors Not Rewarding Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Performance Completely

Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Jul 27
Returns On Capital At Guangzhou Wondfo BiotechLtd (SZSE:300482) Paint A Concerning Picture

Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

Apr 29
Guangzhou Wondfo BiotechLtd's (SZSE:300482) Solid Earnings May Rest On Weak Foundations

A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

Mar 27
A Piece Of The Puzzle Missing From Guangzhou Wondfo Biotech Co.,Ltd's (SZSE:300482) Share Price

There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Feb 29
There Are Reasons To Feel Uneasy About Guangzhou Wondfo BiotechLtd's (SZSE:300482) Returns On Capital

Revenue & Expenses Breakdown

How Guangzhou Wondfo BiotechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300482 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,942524906390
30 Jun 242,852509895385
31 Mar 242,794502895389
31 Dec 232,765488880378
30 Sep 232,989357909369
30 Jun 233,136354880371
31 Mar 233,887497882395
01 Jan 235,6811,1971,175419
30 Sep 225,5501,2471,072424
30 Jun 225,5381,2571,153449
31 Mar 225,2901,3831,191427
31 Dec 213,361634930391
30 Sep 213,145695915339
30 Jun 213,060741870308
31 Mar 212,956692870303
31 Dec 202,811634826279
30 Sep 202,821663867265
30 Jun 202,711630812241
31 Mar 202,172413721182
31 Dec 192,072387667160
30 Sep 191,921375614163
30 Jun 191,817352576153
31 Mar 191,748325538149
31 Dec 181,650308504137
30 Sep 181,542280465116
30 Jun 181,498264408147
31 Mar 181,323231390117
31 Dec 171,14521135692
30 Sep 1792118131462
30 Jun 177471743220
31 Mar 176241542690
31 Dec 165471452350
30 Sep 165251582210
30 Jun 164861472040
31 Mar 164501311890
31 Dec 154291251730
30 Sep 153821061550
30 Jun 153801051480
31 Mar 15365961720
31 Dec 14365981450
31 Dec 1324859950

Quality Earnings: 300482 has high quality earnings.

Growing Profit Margin: 300482's current net profit margins (17.8%) are higher than last year (11.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300482's earnings have grown by 1.1% per year over the past 5 years.

Accelerating Growth: 300482's earnings growth over the past year (46.7%) exceeds its 5-year average (1.1% per year).

Earnings vs Industry: 300482 earnings growth over the past year (46.7%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 300482's Return on Equity (9.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies